Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2012
Dec. 31, 2011
Current Assets    
Cash and cash equivalents $ 569,460 $ 3,569,098
Marketable securities 4,532,864 5,146,823
Restricted cash 553,268 551,883
Accounts receivable - project revenue and reimbursable project costs 420,540 277,211
Prepaid expenses & other current assets 666,487 269,697
Total Current Assets 6,742,619 9,814,712
Property Plant and Equipment - net 43,030 46,514
Other Assets    
Patent costs - net 580,577 537,075
Security deposits 40,162 120,486
Total Other Assets 620,739 657,561
Total Assets 7,406,388 10,518,787
Current Liabilities    
Accounts payable and accrued liabilities 1,094,355 1,680,433
Total Current Liabilities 1,094,355 1,680,433
Stockholders' Equity    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding 0 0
Common stock, $0.001par value, 500,000,000 authorized, 12,539,162 shares issued, 12,523,872 shares outstanding and 12,476,414 shares issued, 12,427,220 shares outstanding at September 30, 2012 and December 31, 2011, respectively 12,524 12,427
Additional paid in capital - stock and stock equivalents 71,811,275 70,946,951
Deficit (65,514,891) (62,155,774)
Common stock reserved for issuance, 1,524 shares and 17,120 shares at September 30, 2012 and December 31, 2011, respectively 3,125 34,750
Total Stockholders' Equity 6,312,033 8,838,354
Total Liabilities and Stockholders' Equity $ 7,406,388 $ 10,518,787